MedPath

A clinical trial to study the effect of addition of dexmedetomidine with local anesthesia on pain relief after arm and hand surgery

Not Applicable
Completed
Conditions
scheduled for forearm and hand surgeries
Registration Number
CTRI/2013/12/004209
Lead Sponsor
Director
Brief Summary

This prospective randomized double blind study was conducted to assess the effects of dexmedetomidine as an adjunct to local anesthetics in supraclavicular brachial plexus block on postoperative analgesia and block characteristics. Sixty adult patients of ASA grade 1 and 2 undergoing upper limb surgery were randomly allocated into two groups. Control group received equal volume of 0.75% ropivacaine and 2% lidocaine with adrenaline (1 in 2,00000) while dexmedetomidine group received I mcg/kg dexmedetomidine along with similar local anesthetics (total volume being 0.5 ml/kg in both groups) in supraclavicular brachial plexus block.Patients were observed for hemodynamic stability, onset and duration of block, postoperative pain, duration of analgesia, sedation and any adverse effects. We observed that addition of dexmedetomidine to local anesthetics in supraclavicular brachial plexus block significantly increases the duration of postoperative analgesia and reduces the requirement of rescue analgesia. The onset of block was faster and the duration was prolonged in dexmedetomidine group as compared to control group. Patients in dexmedetomidine group were sedated but easily arousable. No adverse effects like hypotension, bradycardia, hypoxia or respiratory depression were reported.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

60 patients of either sex aged between 20-60 years, ASA physical status I-II, scheduled for forearm and hand surgeries were included.

Exclusion Criteria

Patients receiving adrenoreceptor agonist or antagonist, neurological deficit in the upper limb, history of cardiac disease, respiratory disease, renal and hepatic failure, pregnant women and allergy to local anesthetics were excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative pain and Duration of analgesia(time interval from administration of block to 1st rescue analgesia required)Postoperative pain was assessed every 30 min for 2 hr, every 1 hr for 6 hr, every 2 hr till 12 hr, | and then at 24 hr postoperatively
Secondary Outcome Measures
NameTimeMethod
onset and duration of sensory and motor blockadeassessed every 5 min till 30 min and then every 30 min till resolution of block

Trial Locations

Locations (1)

Operation Theater Nehru Hospital

🇮🇳

Chandigarh, CHANDIGARH, India

Operation Theater Nehru Hospital
🇮🇳Chandigarh, CHANDIGARH, India
Neerja Bharti
Principal investigator
9915575145
bhartineerja@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.